drugset / Trial / NCT01239511
Phase IIb Study of STA-2 in Patients With Chronic Stable Angina
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the dose-response of three different dose levels of STA-2 (900 mg daily, 1800 mg daily and 2700 mg daily for 42 days) versus placebo in patients with chronic stable angina.
Timeline
- Start
- 2010-11
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | green tea polyphenols | Unknown | 900 mg | Oral |
| Subject | green tea polyphenols | Unknown | 1800 mg | Oral |
| Subject | green tea polyphenols | Unknown | 2700 mg | Oral |